 Patrick Carry
Concepts (399)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scoliosis | 11 | 2023 | 183 | 3.610 |
Why?
| | Acetabulum | 14 | 2023 | 107 | 1.700 |
Why?
| | DNA Methylation | 5 | 2021 | 503 | 1.560 |
Why?
| | Islets of Langerhans | 4 | 2023 | 739 | 1.360 |
Why?
| | Hip Dislocation, Congenital | 9 | 2023 | 42 | 1.330 |
Why?
| | Humeral Fractures | 8 | 2022 | 47 | 1.260 |
Why?
| | Spinal Fusion | 6 | 2022 | 225 | 1.230 |
Why?
| | Fractures, Bone | 8 | 2023 | 380 | 1.150 |
Why?
| | Orthopedic Procedures | 10 | 2020 | 225 | 1.080 |
Why?
| | Autoimmunity | 6 | 2023 | 831 | 0.980 |
Why?
| | Hip Dislocation | 8 | 2023 | 60 | 0.960 |
Why?
| | Adolescent | 58 | 2023 | 18480 | 0.940 |
Why?
| | Diabetes Mellitus, Type 1 | 8 | 2023 | 3360 | 0.900 |
Why?
| | Propensity Score | 3 | 2023 | 242 | 0.890 |
Why?
| | Hip Joint | 9 | 2021 | 144 | 0.880 |
Why?
| | Kyphosis | 1 | 2022 | 34 | 0.850 |
Why?
| | Blood Loss, Surgical | 3 | 2021 | 87 | 0.830 |
Why?
| | Child | 58 | 2023 | 19129 | 0.830 |
Why?
| | Osteotomy | 10 | 2017 | 158 | 0.820 |
Why?
| | Ultrasonic Therapy | 1 | 2021 | 12 | 0.800 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 6 | 2019 | 143 | 0.800 |
Why?
| | Radiography | 21 | 2021 | 861 | 0.780 |
Why?
| | Seroconversion | 1 | 2021 | 48 | 0.780 |
Why?
| | Genome-Wide Association Study | 3 | 2021 | 1323 | 0.740 |
Why?
| | Twins, Monozygotic | 1 | 2021 | 214 | 0.740 |
Why?
| | Diseases in Twins | 1 | 2021 | 181 | 0.740 |
Why?
| | Semicircular Canals | 1 | 2020 | 28 | 0.720 |
Why?
| | Postoperative Complications | 18 | 2020 | 2235 | 0.720 |
Why?
| | Phospholipids | 1 | 2021 | 208 | 0.700 |
Why?
| | Femoracetabular Impingement | 5 | 2020 | 50 | 0.680 |
Why?
| | Retrospective Studies | 50 | 2023 | 12978 | 0.660 |
Why?
| | Surgeons | 1 | 2022 | 243 | 0.650 |
Why?
| | Upper Extremity | 2 | 2023 | 81 | 0.650 |
Why?
| | Health Status | 1 | 2023 | 726 | 0.620 |
Why?
| | Humans | 97 | 2023 | 118974 | 0.610 |
Why?
| | Fracture Fixation | 3 | 2015 | 81 | 0.590 |
Why?
| | Ultrasonography | 5 | 2022 | 716 | 0.590 |
Why?
| | Algorithms | 2 | 2023 | 1541 | 0.590 |
Why?
| | Femur | 5 | 2023 | 199 | 0.560 |
Why?
| | Fracture Fixation, Intramedullary | 4 | 2022 | 54 | 0.550 |
Why?
| | Arteries | 1 | 2018 | 250 | 0.550 |
Why?
| | Athletic Injuries | 6 | 2022 | 495 | 0.550 |
Why?
| | Female | 67 | 2023 | 61565 | 0.540 |
Why?
| | Clavicle | 3 | 2014 | 30 | 0.530 |
Why?
| | Tibial Fractures | 3 | 2023 | 71 | 0.530 |
Why?
| | Male | 67 | 2023 | 57801 | 0.510 |
Why?
| | Pain, Postoperative | 5 | 2018 | 211 | 0.510 |
Why?
| | Lower Extremity | 3 | 2023 | 335 | 0.490 |
Why?
| | Child, Preschool | 18 | 2021 | 9491 | 0.480 |
Why?
| | Anterior Cruciate Ligament Injuries | 4 | 2019 | 147 | 0.470 |
Why?
| | Femur Head | 3 | 2021 | 41 | 0.470 |
Why?
| | Return to Sport | 5 | 2022 | 90 | 0.460 |
Why?
| | Joint Instability | 5 | 2019 | 172 | 0.440 |
Why?
| | Oxylipins | 3 | 2023 | 28 | 0.440 |
Why?
| | Snow Sports | 1 | 2012 | 1 | 0.430 |
Why?
| | Head Protective Devices | 1 | 2012 | 17 | 0.430 |
Why?
| | Femur Head Necrosis | 3 | 2016 | 8 | 0.420 |
Why?
| | Treatment Outcome | 29 | 2023 | 9342 | 0.420 |
Why?
| | Case-Control Studies | 8 | 2023 | 3171 | 0.390 |
Why?
| | Insulin | 2 | 2021 | 2162 | 0.390 |
Why?
| | Epiphyses | 7 | 2021 | 20 | 0.380 |
Why?
| | Patellofemoral Pain Syndrome | 1 | 2010 | 8 | 0.380 |
Why?
| | Pronation | 1 | 2010 | 9 | 0.380 |
Why?
| | Patellofemoral Joint | 1 | 2010 | 9 | 0.380 |
Why?
| | Brain Concussion | 3 | 2022 | 470 | 0.370 |
Why?
| | Fracture Fixation, Internal | 6 | 2020 | 187 | 0.370 |
Why?
| | Bone Nails | 4 | 2019 | 60 | 0.370 |
Why?
| | Osteogenesis Imperfecta | 2 | 2020 | 16 | 0.360 |
Why?
| | Magnetic Resonance Imaging | 6 | 2022 | 3174 | 0.360 |
Why?
| | Parent-Child Relations | 1 | 2012 | 232 | 0.360 |
Why?
| | Manipulation, Orthopedic | 3 | 2019 | 8 | 0.340 |
Why?
| | Severity of Illness Index | 7 | 2021 | 2674 | 0.330 |
Why?
| | Casts, Surgical | 2 | 2019 | 31 | 0.300 |
Why?
| | Clubfoot | 2 | 2019 | 14 | 0.300 |
Why?
| | Slipped Capital Femoral Epiphyses | 2 | 2018 | 6 | 0.290 |
Why?
| | Disease Progression | 4 | 2022 | 2490 | 0.290 |
Why?
| | Prevalence | 4 | 2022 | 2326 | 0.290 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 251 | 0.280 |
Why?
| | Spine | 2 | 2018 | 144 | 0.280 |
Why?
| | Sports | 2 | 2022 | 194 | 0.280 |
Why?
| | Cohort Studies | 8 | 2021 | 5116 | 0.280 |
Why?
| | Clinical Protocols | 2 | 2018 | 238 | 0.280 |
Why?
| | Risk Factors | 15 | 2023 | 9000 | 0.270 |
Why?
| | Athletes | 5 | 2022 | 353 | 0.260 |
Why?
| | Charcot-Marie-Tooth Disease | 2 | 2016 | 19 | 0.260 |
Why?
| | Young Adult | 15 | 2022 | 10793 | 0.260 |
Why?
| | Tibial Meniscus Injuries | 2 | 2015 | 46 | 0.250 |
Why?
| | Tibia | 2 | 2023 | 177 | 0.250 |
Why?
| | Range of Motion, Articular | 7 | 2022 | 369 | 0.250 |
Why?
| | Infant | 12 | 2023 | 8293 | 0.240 |
Why?
| | Elbow Joint | 3 | 2019 | 63 | 0.240 |
Why?
| | Sternoclavicular Joint | 2 | 2014 | 8 | 0.240 |
Why?
| | Cartilage, Articular | 2 | 2020 | 306 | 0.240 |
Why?
| | Orthotic Devices | 3 | 2022 | 30 | 0.230 |
Why?
| | Odds Ratio | 8 | 2019 | 996 | 0.230 |
Why?
| | Time Factors | 13 | 2021 | 6412 | 0.230 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 75 | 0.230 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 77 | 0.230 |
Why?
| | Reoperation | 6 | 2017 | 557 | 0.230 |
Why?
| | Tomography, X-Ray Computed | 3 | 2019 | 2436 | 0.220 |
Why?
| | Growth Plate | 2 | 2023 | 34 | 0.220 |
Why?
| | Humerus | 2 | 2022 | 44 | 0.220 |
Why?
| | Epigenesis, Genetic | 3 | 2021 | 539 | 0.220 |
Why?
| | Meniere Disease | 1 | 2023 | 30 | 0.220 |
Why?
| | Adult | 18 | 2023 | 31512 | 0.210 |
Why?
| | Gait Disorders, Neurologic | 1 | 2022 | 40 | 0.210 |
Why?
| | Hip Fractures | 1 | 2023 | 79 | 0.210 |
Why?
| | Spinal Fractures | 1 | 2023 | 77 | 0.210 |
Why?
| | Migraine Disorders | 1 | 2023 | 79 | 0.210 |
Why?
| | Orthopedic Surgeons | 1 | 2022 | 19 | 0.210 |
Why?
| | Quadriceps Muscle | 3 | 2022 | 101 | 0.210 |
Why?
| | Ankle Fractures | 1 | 2022 | 19 | 0.210 |
Why?
| | Deafness | 1 | 2023 | 79 | 0.210 |
Why?
| | Legg-Calve-Perthes Disease | 1 | 2021 | 2 | 0.200 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 47 | 0.200 |
Why?
| | Selection Bias | 1 | 2021 | 35 | 0.200 |
Why?
| | Cerebral Palsy | 1 | 2022 | 80 | 0.200 |
Why?
| | Age Factors | 7 | 2021 | 2995 | 0.200 |
Why?
| | Biomechanical Phenomena | 5 | 2022 | 683 | 0.200 |
Why?
| | Orthognathic Surgical Procedures | 1 | 2001 | 5 | 0.200 |
Why?
| | Neck Muscles | 1 | 2021 | 12 | 0.200 |
Why?
| | Incidence | 8 | 2023 | 2424 | 0.190 |
Why?
| | Follow-Up Studies | 10 | 2021 | 4596 | 0.190 |
Why?
| | Prosthesis Fitting | 1 | 2020 | 14 | 0.190 |
Why?
| | Pelvic Bones | 1 | 2023 | 127 | 0.190 |
Why?
| | Monitoring, Intraoperative | 2 | 2016 | 43 | 0.190 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 215 | 0.190 |
Why?
| | Probability | 1 | 2021 | 305 | 0.190 |
Why?
| | Arthralgia | 2 | 2020 | 51 | 0.190 |
Why?
| | Suture Techniques | 2 | 2019 | 134 | 0.180 |
Why?
| | Muscle Strength | 2 | 2021 | 283 | 0.180 |
Why?
| | Bias | 1 | 2021 | 198 | 0.180 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1125 | 0.180 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 131 | 0.180 |
Why?
| | Patella | 1 | 2019 | 25 | 0.180 |
Why?
| | Play and Playthings | 1 | 2019 | 30 | 0.180 |
Why?
| | Intraoperative Complications | 1 | 2001 | 132 | 0.180 |
Why?
| | Recreation | 1 | 2019 | 26 | 0.180 |
Why?
| | Histology | 1 | 2019 | 3 | 0.170 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2019 | 13 | 0.170 |
Why?
| | Education, Professional | 1 | 2019 | 18 | 0.170 |
Why?
| | Health Occupations | 1 | 2019 | 30 | 0.170 |
Why?
| | Equipment Failure | 1 | 2019 | 114 | 0.170 |
Why?
| | Gene Frequency | 1 | 2020 | 513 | 0.160 |
Why?
| | Logistic Models | 5 | 2017 | 1901 | 0.160 |
Why?
| | Tendons | 1 | 2019 | 137 | 0.160 |
Why?
| | Computer-Assisted Instruction | 1 | 2019 | 66 | 0.160 |
Why?
| | Pattern Recognition, Visual | 1 | 2019 | 89 | 0.160 |
Why?
| | Anesthesia, Local | 1 | 2018 | 17 | 0.160 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2018 | 10 | 0.160 |
Why?
| | Interleukins | 1 | 2020 | 242 | 0.160 |
Why?
| | Prader-Willi Syndrome | 1 | 2018 | 27 | 0.160 |
Why?
| | Femoral Nerve | 1 | 2018 | 17 | 0.160 |
Why?
| | Bone Malalignment | 1 | 2017 | 14 | 0.160 |
Why?
| | Genetic Association Studies | 1 | 2020 | 371 | 0.160 |
Why?
| | Analgesia, Epidural | 1 | 2018 | 21 | 0.160 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 324 | 0.160 |
Why?
| | Autoantibodies | 2 | 2022 | 1335 | 0.160 |
Why?
| | Meningomyelocele | 1 | 2018 | 51 | 0.160 |
Why?
| | Sciatic Nerve | 1 | 2018 | 59 | 0.150 |
Why?
| | Collagen | 1 | 2020 | 433 | 0.150 |
Why?
| | Arthroscopy | 2 | 2020 | 234 | 0.150 |
Why?
| | Femoral Fractures | 1 | 2018 | 67 | 0.150 |
Why?
| | Bone Plates | 1 | 2018 | 74 | 0.150 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 100 | 0.150 |
Why?
| | Nerve Block | 1 | 2018 | 67 | 0.150 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 401 | 0.150 |
Why?
| | Cumulative Trauma Disorders | 1 | 2016 | 30 | 0.140 |
Why?
| | Immunity, Innate | 1 | 2022 | 745 | 0.140 |
Why?
| | Learning Curve | 1 | 2017 | 67 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 499 | 0.140 |
Why?
| | Epiphyses, Slipped | 1 | 2016 | 4 | 0.140 |
Why?
| | Open Fracture Reduction | 1 | 2016 | 26 | 0.140 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 4552 | 0.140 |
Why?
| | Metabolomics | 1 | 2021 | 550 | 0.140 |
Why?
| | Prospective Studies | 7 | 2023 | 6471 | 0.140 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2016 | 51 | 0.140 |
Why?
| | Pain | 1 | 2022 | 735 | 0.140 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 79 | 0.140 |
Why?
| | Electrocardiography | 2 | 2016 | 556 | 0.130 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 1868 | 0.130 |
Why?
| | Radius | 1 | 2015 | 33 | 0.130 |
Why?
| | Caregivers | 1 | 2022 | 709 | 0.130 |
Why?
| | Shoulder Fractures | 1 | 2015 | 13 | 0.130 |
Why?
| | Forecasting | 1 | 2016 | 353 | 0.130 |
Why?
| | Soft Tissue Injuries | 1 | 2015 | 35 | 0.130 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 67 | 0.130 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1200 | 0.130 |
Why?
| | Elective Surgical Procedures | 1 | 2016 | 160 | 0.130 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2275 | 0.130 |
Why?
| | Long QT Syndrome | 1 | 2015 | 57 | 0.120 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2014 | 35 | 0.120 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 244 | 0.120 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 45 | 0.120 |
Why?
| | Menisci, Tibial | 1 | 2014 | 59 | 0.120 |
Why?
| | Autografts | 1 | 2014 | 49 | 0.120 |
Why?
| | Patient Compliance | 1 | 2018 | 537 | 0.120 |
Why?
| | Bone Diseases | 1 | 2014 | 59 | 0.120 |
Why?
| | Diet | 1 | 2021 | 1153 | 0.120 |
Why?
| | Venous Thrombosis | 1 | 2016 | 147 | 0.120 |
Why?
| | Allografts | 1 | 2014 | 135 | 0.120 |
Why?
| | Prescription Drugs | 1 | 2015 | 113 | 0.120 |
Why?
| | Obesity | 3 | 2015 | 2746 | 0.120 |
Why?
| | Pulmonary Embolism | 1 | 2016 | 183 | 0.120 |
Why?
| | Joint Dislocations | 1 | 2014 | 59 | 0.120 |
Why?
| | Risk Assessment | 7 | 2017 | 3057 | 0.120 |
Why?
| | Cartilage | 1 | 2015 | 183 | 0.110 |
Why?
| | Body Mass Index | 3 | 2016 | 2092 | 0.110 |
Why?
| | Clinical Competence | 2 | 2017 | 951 | 0.110 |
Why?
| | Shoulder Dislocation | 1 | 2014 | 56 | 0.110 |
Why?
| | Injury Severity Score | 3 | 2023 | 528 | 0.110 |
Why?
| | Chi-Square Distribution | 4 | 2015 | 525 | 0.110 |
Why?
| | United States | 9 | 2022 | 12555 | 0.110 |
Why?
| | Intra-Articular Fractures | 1 | 2012 | 20 | 0.110 |
Why?
| | Bupivacaine | 1 | 2012 | 34 | 0.110 |
Why?
| | Pediatrics | 1 | 2020 | 985 | 0.110 |
Why?
| | Anemia, Sickle Cell | 1 | 2015 | 230 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 4 | 2016 | 842 | 0.110 |
Why?
| | Amides | 1 | 2012 | 86 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2062 | 0.100 |
Why?
| | Knee Joint | 3 | 2022 | 353 | 0.100 |
Why?
| | Bone and Bones | 1 | 2014 | 289 | 0.100 |
Why?
| | Graft Survival | 1 | 2014 | 504 | 0.100 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1474 | 0.100 |
Why?
| | Treatment Failure | 3 | 2019 | 341 | 0.100 |
Why?
| | CpG Islands | 2 | 2021 | 119 | 0.100 |
Why?
| | Operative Time | 3 | 2017 | 114 | 0.100 |
Why?
| | Recovery of Function | 4 | 2016 | 604 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2015 | 523 | 0.100 |
Why?
| | Reproducibility of Results | 4 | 2020 | 2874 | 0.100 |
Why?
| | Linear Models | 3 | 2021 | 827 | 0.100 |
Why?
| | Aged, 80 and over | 2 | 2021 | 6561 | 0.090 |
Why?
| | Craniocerebral Trauma | 1 | 2012 | 146 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 794 | 0.090 |
Why?
| | North America | 1 | 2011 | 266 | 0.090 |
Why?
| | Sex Factors | 3 | 2021 | 1781 | 0.090 |
Why?
| | Torque | 2 | 2021 | 67 | 0.090 |
Why?
| | Trauma Centers | 2 | 2022 | 388 | 0.090 |
Why?
| | Emergency Medical Services | 1 | 2016 | 589 | 0.090 |
Why?
| | Mice | 2 | 2023 | 15520 | 0.090 |
Why?
| | Data Collection | 1 | 2012 | 658 | 0.080 |
Why?
| | Neuromuscular Diseases | 1 | 2010 | 90 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2174 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2011 | 546 | 0.080 |
Why?
| | Facial Bones | 2 | 2001 | 33 | 0.080 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1510 | 0.080 |
Why?
| | Cadaver | 2 | 2020 | 327 | 0.080 |
Why?
| | Postoperative Care | 3 | 2015 | 237 | 0.080 |
Why?
| | Equipment Failure Analysis | 2 | 2020 | 139 | 0.080 |
Why?
| | Observer Variation | 2 | 2018 | 309 | 0.080 |
Why?
| | Regression Analysis | 2 | 2019 | 983 | 0.070 |
Why?
| | Bone Transplantation | 2 | 2019 | 99 | 0.070 |
Why?
| | Hemodilution | 2 | 1996 | 10 | 0.070 |
Why?
| | Equipment Design | 2 | 2019 | 519 | 0.070 |
Why?
| | Patient Care Team | 1 | 2010 | 521 | 0.070 |
Why?
| | Infant, Newborn | 4 | 2019 | 5255 | 0.070 |
Why?
| | Prognosis | 3 | 2020 | 3443 | 0.070 |
Why?
| | Animals | 2 | 2023 | 33381 | 0.060 |
Why?
| | Knee Injuries | 2 | 2015 | 103 | 0.060 |
Why?
| | Vertigo | 1 | 2023 | 35 | 0.060 |
Why?
| | Pain Measurement | 2 | 2018 | 469 | 0.060 |
Why?
| | Colorado | 3 | 2018 | 4196 | 0.060 |
Why?
| | Patient Satisfaction | 2 | 2018 | 610 | 0.050 |
Why?
| | Pelvis | 1 | 2023 | 92 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2023 | 120 | 0.050 |
Why?
| | Physical Therapy Modalities | 2 | 2015 | 274 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 133 | 0.050 |
Why?
| | Fracture Healing | 1 | 2022 | 74 | 0.050 |
Why?
| | Anatomic Variation | 1 | 2021 | 5 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 61 | 0.050 |
Why?
| | Peripheral Nerves | 1 | 2022 | 65 | 0.050 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 58 | 0.050 |
Why?
| | Standard of Care | 1 | 2022 | 63 | 0.050 |
Why?
| | Preanesthetic Medication | 1 | 2001 | 4 | 0.050 |
Why?
| | Chin | 1 | 2001 | 5 | 0.050 |
Why?
| | Osteotomy, Le Fort | 1 | 2001 | 3 | 0.050 |
Why?
| | Pulmonary Atelectasis | 1 | 2001 | 13 | 0.050 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2001 | 13 | 0.050 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 51 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2021 | 41 | 0.050 |
Why?
| | Malocclusion | 1 | 2001 | 25 | 0.050 |
Why?
| | Muscle Strength Dynamometer | 1 | 2021 | 22 | 0.050 |
Why?
| | Osteogenesis, Distraction | 1 | 2001 | 11 | 0.050 |
Why?
| | Work | 1 | 2020 | 18 | 0.050 |
Why?
| | Arachidonic Acid | 1 | 2021 | 122 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 70 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2001 | 48 | 0.050 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 159 | 0.050 |
Why?
| | Blood | 1 | 2001 | 100 | 0.050 |
Why?
| | Emergency Service, Hospital | 2 | 2023 | 1865 | 0.050 |
Why?
| | Musculoskeletal System | 1 | 2021 | 55 | 0.050 |
Why?
| | Middle Aged | 6 | 2018 | 27617 | 0.050 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.050 |
Why?
| | Athletic Performance | 1 | 2020 | 46 | 0.050 |
Why?
| | Fetal Blood | 1 | 2021 | 272 | 0.050 |
Why?
| | Gait | 1 | 2022 | 253 | 0.050 |
Why?
| | Functional Laterality | 1 | 2020 | 208 | 0.050 |
Why?
| | Patellar Ligament | 1 | 2019 | 26 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2001 | 98 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2019 | 49 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 437 | 0.040 |
Why?
| | Isometric Contraction | 1 | 2021 | 155 | 0.040 |
Why?
| | Ligaments | 1 | 2019 | 47 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 490 | 0.040 |
Why?
| | Radiation Dosage | 1 | 2020 | 147 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 125 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 770 | 0.040 |
Why?
| | Sutures | 1 | 2019 | 61 | 0.040 |
Why?
| | Students, Health Occupations | 1 | 2019 | 23 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 421 | 0.040 |
Why?
| | Eye Movements | 1 | 2019 | 56 | 0.040 |
Why?
| | Professional Competence | 1 | 2019 | 91 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 598 | 0.040 |
Why?
| | Anterior Cruciate Ligament | 1 | 2019 | 89 | 0.040 |
Why?
| | Breast Feeding | 1 | 2021 | 386 | 0.040 |
Why?
| | Video Recording | 1 | 2019 | 156 | 0.040 |
Why?
| | Comorbidity | 2 | 2015 | 1527 | 0.040 |
Why?
| | Random Allocation | 1 | 2019 | 344 | 0.040 |
Why?
| | Thoracic Vertebrae | 1 | 2018 | 72 | 0.040 |
Why?
| | Risk Management | 1 | 2018 | 90 | 0.040 |
Why?
| | Organ Size | 1 | 2018 | 460 | 0.040 |
Why?
| | Device Removal | 1 | 2018 | 127 | 0.040 |
Why?
| | Calcium | 1 | 2023 | 1169 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2018 | 230 | 0.040 |
Why?
| | Age of Onset | 1 | 2018 | 467 | 0.040 |
Why?
| | Intestinal Fistula | 1 | 1996 | 12 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1231 | 0.030 |
Why?
| | Ileostomy | 1 | 1996 | 18 | 0.030 |
Why?
| | Ribs | 1 | 2015 | 33 | 0.030 |
Why?
| | Intracranial Pressure | 1 | 2016 | 53 | 0.030 |
Why?
| | Inservice Training | 1 | 2016 | 106 | 0.030 |
Why?
| | Missouri | 1 | 2015 | 63 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 122 | 0.030 |
Why?
| | Intestinal Obstruction | 1 | 1996 | 41 | 0.030 |
Why?
| | Methylprednisolone | 1 | 1996 | 84 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 309 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 296 | 0.030 |
Why?
| | Titanium | 1 | 2015 | 67 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 39 | 0.030 |
Why?
| | Radiologic Health | 1 | 2015 | 5 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1440 | 0.030 |
Why?
| | Esthetics | 1 | 2015 | 36 | 0.030 |
Why?
| | Curettage | 1 | 2014 | 9 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2015 | 191 | 0.030 |
Why?
| | Rotation | 1 | 2015 | 121 | 0.030 |
Why?
| | Medical Records | 1 | 2015 | 163 | 0.030 |
Why?
| | Lysholm Knee Score | 1 | 2014 | 8 | 0.030 |
Why?
| | Skull | 1 | 1996 | 127 | 0.030 |
Why?
| | Pain Management | 1 | 2018 | 294 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 2015 | 127 | 0.030 |
Why?
| | Cost Savings | 1 | 2015 | 77 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 473 | 0.030 |
Why?
| | Coxa Valga | 1 | 2014 | 1 | 0.030 |
Why?
| | Edema | 1 | 1995 | 124 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2016 | 418 | 0.030 |
Why?
| | Occupational Therapy | 1 | 2015 | 73 | 0.030 |
Why?
| | Hospitalization | 1 | 2023 | 1785 | 0.030 |
Why?
| | Immobilization | 1 | 2014 | 47 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2014 | 70 | 0.030 |
Why?
| | Age Distribution | 1 | 2015 | 362 | 0.030 |
Why?
| | Sex Distribution | 1 | 2015 | 351 | 0.030 |
Why?
| | Physical Examination | 1 | 2015 | 243 | 0.030 |
Why?
| | Osteoarthritis, Hip | 1 | 2014 | 45 | 0.030 |
Why?
| | Face | 1 | 1995 | 165 | 0.030 |
Why?
| | Preoperative Care | 1 | 2015 | 332 | 0.030 |
Why?
| | Self Report | 1 | 2016 | 699 | 0.030 |
Why?
| | Injections, Intra-Articular | 1 | 2012 | 62 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 1996 | 465 | 0.030 |
Why?
| | Quality of Life | 1 | 2023 | 2366 | 0.030 |
Why?
| | Anesthetics, Local | 1 | 2012 | 85 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2012 | 269 | 0.030 |
Why?
| | Disease Management | 1 | 2015 | 571 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1079 | 0.020 |
Why?
| | Patient Selection | 1 | 2014 | 676 | 0.020 |
Why?
| | Communication | 1 | 2016 | 761 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 736 | 0.020 |
Why?
| | Quality Improvement | 1 | 2018 | 963 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1293 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 505 | 0.020 |
Why?
| | Lung | 1 | 2001 | 3664 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 1945 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4708 | 0.020 |
Why?
| | Critical Care | 1 | 2010 | 492 | 0.020 |
Why?
| | Acute-Phase Proteins | 2 | 1996 | 67 | 0.020 |
Why?
| | Length of Stay | 1 | 2010 | 1032 | 0.020 |
Why?
| | Inflammation | 1 | 1996 | 2566 | 0.020 |
Why?
| | Orosomucoid | 1 | 1995 | 5 | 0.010 |
Why?
| | Telemetry | 1 | 1995 | 32 | 0.010 |
Why?
| | Haptoglobins | 1 | 1995 | 49 | 0.010 |
Why?
| | Blood Volume | 1 | 1995 | 58 | 0.010 |
Why?
| | Hematocrit | 1 | 1995 | 91 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 65 | 0.010 |
Why?
| | Rectal Neoplasms | 1 | 1996 | 121 | 0.010 |
Why?
| | Morbidity | 1 | 1996 | 296 | 0.010 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 105 | 0.010 |
Why?
| | Fibrinogen | 1 | 1995 | 161 | 0.010 |
Why?
| | C-Reactive Protein | 1 | 1995 | 360 | 0.010 |
Why?
| | Crohn Disease | 1 | 1996 | 197 | 0.010 |
Why?
| | Aged | 1 | 1996 | 19657 | 0.000 |
Why?
|
|
Carry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|